Abstract:Background: Gene fusions, resulting from chromosomal rearrangements, play a critical role in the oncogenesis of various cancers, often acting as diagnostic markers and therapeutic targets. Their detection is important for understanding tumor biology and guiding personalized treatment strategies. With the evolution of economical sequencing technologies, hypothesis-free gene fusion detection in cancer genomics is becoming more accessible. This study demonstrates the use of the cost-effective Ultima Genomics UG100 platform for a comprehensive analysis of gene fusions, uniquely integrating Whole Genome Sequencing (WGS) and Whole Transcriptome Sequencing (WTS). This integration capitalizes on the strengths of both methods: WGS, which enables a broad analysis of structural variations including extragenic events, and WTS for more functional characterization of expressed gene fusions and abnormal isoforms, offering a synergistic approach that enhances the detection and characterization of genomic rearrangements. Methods: Five cancer cell lines (K562, THP-1, NCI-H660, Kasumi-1, MV4-11) with 29 previously detected gene fusions were sequenced, using both WTS and WGS, in addition to a standard fusion reference sample (Seraseq Fusion RNA Mix, with 16 RNA fusions). The libraries were sequenced on a UG100 sequencer using single ended reads of length ~250bp and analyzed with publicly available software: STAR-Fusion, combined with FusionInspector were used to detect RNA fusions; Manta and GridSS were used to detect DNA structural variations, including translocations. Results: 93% of the documented fusion events were detected in DNA and in RNA, in addition to the 16 evaluated just in RNA (100% detected). Sequence data from both WTS and WGS on the UG100 platform successfully identified a spectrum of gene fusions in both DNA and RNA, thereby confirming the platform's detection capabilities in both types of assays. The structural variation events detected in the WGS were comprised mainly of translocations, but also deletions and duplications. Conclusions: The Ultima Genomics UG100 sequencer has proven to be a cost-effective and efficient tool for the genome-wide discovery and validation of gene fusions, which can be impactful in clinical oncology settings. This study underscores the potential of using an integrated WTS and WGS approach on a single platform to advance our understanding of the genomic complexity of cancer, paving the way for more effective diagnostic and therapeutic strategies. Citation Format: Gila Lithwick-Yanai, Sarah Pollock, Danit Lebanony, Keren Ben Simhon, Sima Benjamin, David Bogumil, Nika Iremadze, Matt Sexton, Peleg Winer, Maya Levy, Shlomit Gilad, Josh Haimes, Giulia Corbet, Jennifer Pavlica, Doron Lipson. Cost-effective, comprehensive detection of gene fusions from DNA and RNA using the UG100 sequencer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 315.

Fusion FISH imaging: single-molecule detection of gene fusion transcripts in situ

Single-cell gene fusion detection by scFusion

SeekFusion - A Clinically Validated Fusion Transcript Detection Pipeline for PCR-Based Next-Generation Sequencing of RNA

Abstract 7418: LongFuse: Detecting gene fusion transcripts from high throughput long-read single cell RNA sequencing data

Transcriptome Sequencing to Detect Gene Fusions in Cancer

Real-time Quantification of Fusion Transcripts with Ligase Chain Reaction by Direct Ligation of Adjacent DNA Probes at Fusion Junction

Diagnostic Utility of Gene Fusion Panel to Detect Gene Fusions in Fresh and Formalin-Fixed, Paraffin-Embedded Cancer Specimens

A Nanopore Sequencing-Based Assay for Rapid Detection of Gene Fusions

Challenges and Prospects in Utilizing Technologies for Gene Fusion Analysis in Cancer Diagnostics

Simultaneous Detection of Gene Fusions and Base Mutations in Cancer Tissue Biopsies by Sequencing Dual Nucleic Acid Templates in Unified Reaction.

mRNA Capture Sequencing and RT-qPCR for the Detection of Pathognomonic, Novel, and Secondary Fusion Transcripts in FFPE Tissue: A Sarcoma Showcase

Identification of Cancer Gene Fusions Based on Advanced Analysis of the Human Genome or Transcriptome

Development and Evaluation of a Pan-Sarcoma Fusion Gene Detection Assay Using the NanoString nCounter Platform

CTAT-LR-fusion: accurate fusion transcript identification from long and short read isoform sequencing at bulk or single cell resolution

Abstract 315: Cost-effective, comprehensive detection of gene fusions from DNA and RNA using the UG100 sequencer

FusionQ: a Novel Approach for Gene Fusion Detection and Quantification from Paired-End RNA-Seq.

Fluorescence Resonance Energy Transfer-Based Hybridization Chain Reaction for in Situ Visualization of Tumor-Related Mrna.

A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis

Detection of sarcoma fusions by a next-generation sequencing based–ligation-dependent multiplex RT-PCR assay

Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR-Based Targeted Next-Generation Sequencing

Mutational profiling in acute lymphoblastic leukemia by RNA sequencing and chromosomal genomic array testing